Medtronic Stock Based Compensation from 2010 to 2025

MDT Stock

USD 92.02 1.28 1.41%

Medtronic PLC Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation will likely drop to about 313 M in 2025. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2007-10-31

Previous Quarter

159 M

Current Value

98 M

Quarterly Volatility

108.3 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Medtronic PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medtronic PLC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.2 B, Interest Expense of 868.2 M or Total Revenue of 39.1 B, as well as many indicators such as Price To Sales Ratio of 5.29, Dividend Yield of 0.011 or PTB Ratio of 5.46. Medtronic financial statements analysis is a perfect complement when working with Medtronic PLC Valuation or Volatility modules.

Check out the analysis of Medtronic PLC Correlation against competitors.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

Latest Medtronic PLC's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Medtronic PLC over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Medtronic PLC's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medtronic PLC's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Medtronic Stock Based Compensation Regression Statistics

	Arithmetic Mean	298,505,500
	Geometric Mean	239,760,019
	Coefficient Of Variation	40.59
	Mean Deviation	92,241,625
	Median	344,000,000
	Standard Deviation	121,165,360
	Sample Variance	14681T
	Range	443.9M
	R-Value	0.69
	Mean Square Error	8203.9T
	R-Squared	0.48
	Significance	0
	Slope	17,603,559
	Total Sum of Squares	220215.7T

Medtronic Stock Based Compensation History

	2025	313 M
	2024	451.9 M
	2023	393 M
	2022	355 M
	2021	359 M
	2019	297 M
	2018	290 M

Other Fundumenentals of Medtronic PLC

Stock Based Compensation To Revenue

Medtronic PLC Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Long Term Debt	Good Will	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Long Term Investments	Short Long Term Debt	Net Tangible Assets	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Cash And Equivalents	Net Working Capital
Total Assets		0.99	0.97	0.78	0.9	0.99	0.89	0.24	0.88	0.88	0.89	0.98	0.38	-0.97	0.84	0.42	-0.71	-0.86	0.16	0.49	-0.69	-0.61	-0.53	-0.48	0.17
Total Stockholder Equity	0.99		0.94	0.74	0.89	0.96	0.86	0.18	0.84	0.92	0.86	0.99	0.31	-0.98	0.88	0.32	-0.78	-0.89	0.22	0.39	-0.77	-0.69	-0.6	-0.55	0.2
Net Debt	0.97	0.94		0.84	0.9	0.99	0.89	0.26	0.87	0.82	0.88	0.93	0.45	-0.91	0.82	0.55	-0.56	-0.8	0.15	0.58	-0.56	-0.51	-0.47	-0.45	0.02
Retained Earnings	0.78	0.74	0.84		0.77	0.82	0.8	0.02	0.77	0.58	0.8	0.71	0.6	-0.68	0.6	0.62	-0.29	-0.69	-0.01	0.7	-0.21	-0.18	-0.21	-0.2	-0.1
Net Receivables	0.9	0.89	0.9	0.77		0.88	0.91	0.12	0.69	0.83	0.77	0.86	0.47	-0.8	0.82	0.28	-0.59	-0.74	0.21	0.33	-0.57	-0.57	-0.56	-0.53	0.07
Total Liab	0.99	0.96	0.99	0.82	0.88		0.9	0.3	0.92	0.81	0.91	0.95	0.45	-0.94	0.78	0.54	-0.61	-0.82	0.08	0.6	-0.59	-0.5	-0.43	-0.38	0.13
Total Current Assets	0.89	0.86	0.89	0.8	0.91	0.9		0.24	0.76	0.72	0.82	0.81	0.72	-0.78	0.69	0.43	-0.49	-0.65	0.06	0.5	-0.46	-0.4	-0.37	-0.32	0.05
Short Term Debt	0.24	0.18	0.26	0.02	0.12	0.3	0.24		0.29	0.02	0.18	0.13	0.13	-0.19	-0.06	0.47	0.06	0.2	-0.23	0.35	-0.15	0.08	0.2	0.27	-0.28
Intangible Assets	0.88	0.84	0.87	0.77	0.69	0.92	0.76	0.29		0.59	0.91	0.83	0.42	-0.88	0.53	0.68	-0.48	-0.76	-0.21	0.78	-0.43	-0.24	-0.18	-0.09	0.25
Accounts Payable	0.88	0.92	0.82	0.58	0.83	0.81	0.72	0.02	0.59		0.67	0.94	0.12	-0.88	0.98	0.04	-0.86	-0.86	0.51	0.07	-0.86	-0.89	-0.79	-0.8	0.14
Long Term Debt	0.89	0.86	0.88	0.8	0.77	0.91	0.82	0.18	0.91	0.67		0.84	0.54	-0.88	0.63	0.58	-0.58	-0.8	-0.09	0.67	-0.41	-0.32	-0.17	-0.23	0.3
Good Will	0.98	0.99	0.93	0.71	0.86	0.95	0.81	0.13	0.83	0.94	0.84		0.24	-0.98	0.9	0.29	-0.8	-0.92	0.26	0.36	-0.79	-0.72	-0.64	-0.59	0.22
Short Term Investments	0.38	0.31	0.45	0.6	0.47	0.45	0.72	0.13	0.42	0.12	0.54	0.24		-0.25	0.11	0.51	0.05	-0.13	-0.25	0.57	0.17	0.21	0.22	0.18	-0.09
Common Stock	-0.97	-0.98	-0.91	-0.68	-0.8	-0.94	-0.78	-0.19	-0.88	-0.88	-0.88	-0.98	-0.25		-0.82	-0.35	0.8	0.91	-0.15	-0.43	0.76	0.65	0.52	0.49	-0.3
Property Plant Equipment	0.84	0.88	0.82	0.6	0.82	0.78	0.69	-0.06	0.53	0.98	0.63	0.9	0.11	-0.82		0.03	-0.79	-0.84	0.55	0.05	-0.78	-0.87	-0.8	-0.84	0.08
Current Deferred Revenue	0.42	0.32	0.55	0.62	0.28	0.54	0.43	0.47	0.68	0.04	0.58	0.29	0.51	-0.35	0.03		0.21	-0.17	-0.45	0.95	0.21	0.37	0.38	0.36	-0.23
Long Term Investments	-0.71	-0.78	-0.56	-0.29	-0.59	-0.61	-0.49	0.06	-0.48	-0.86	-0.58	-0.8	0.05	0.8	-0.79	0.21		0.79	-0.41	0.13	0.9	0.86	0.67	0.68	-0.46
Short Long Term Debt	-0.86	-0.89	-0.8	-0.69	-0.74	-0.82	-0.65	0.2	-0.76	-0.86	-0.8	-0.92	-0.13	0.91	-0.84	-0.17	0.79		-0.24	-0.32	0.67	0.66	0.59	0.6	-0.4
Net Tangible Assets	0.16	0.22	0.15	-0.01	0.21	0.08	0.06	-0.23	-0.21	0.51	-0.09	0.26	-0.25	-0.15	0.55	-0.45	-0.41	-0.24		-0.5	-0.48	-0.68	-0.71	-0.8	-0.26
Deferred Long Term Liab	0.49	0.39	0.58	0.7	0.33	0.6	0.5	0.35	0.78	0.07	0.67	0.36	0.57	-0.43	0.05	0.95	0.13	-0.32	-0.5		0.18	0.35	0.35	0.37	-0.07
Long Term Debt Total	-0.69	-0.77	-0.56	-0.21	-0.57	-0.59	-0.46	-0.15	-0.43	-0.86	-0.41	-0.79	0.17	0.76	-0.78	0.21	0.9	0.67	-0.48	0.18		0.92	0.81	0.7	-0.2
Capital Surpluse	-0.61	-0.69	-0.51	-0.18	-0.57	-0.5	-0.4	0.08	-0.24	-0.89	-0.32	-0.72	0.21	0.65	-0.87	0.37	0.86	0.66	-0.68	0.35	0.92		0.91	0.88	-0.14
Net Invested Capital	-0.53	-0.6	-0.47	-0.21	-0.56	-0.43	-0.37	0.2	-0.18	-0.79	-0.17	-0.64	0.22	0.52	-0.8	0.38	0.67	0.59	-0.71	0.35	0.81	0.91		0.85	0.02
Cash And Equivalents	-0.48	-0.55	-0.45	-0.2	-0.53	-0.38	-0.32	0.27	-0.09	-0.8	-0.23	-0.59	0.18	0.49	-0.84	0.36	0.68	0.6	-0.8	0.37	0.7	0.88	0.85		-0.01
Net Working Capital	0.17	0.2	0.02	-0.1	0.07	0.13	0.05	-0.28	0.25	0.14	0.3	0.22	-0.09	-0.3	0.08	-0.23	-0.46	-0.4	-0.26	-0.07	-0.2	-0.14	0.02	-0.01

Click cells to compare fundamentals

About Medtronic PLC Financial Statements

Medtronic PLC shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Medtronic PLC investors may analyze each financial statement separately, they are all interrelated. The changes in Medtronic PLC's assets and liabilities, for example, are also reflected in the revenues and expenses on on Medtronic PLC's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Stock Based Compensation	451.9 M	313 M
Stock Based Compensation To Revenue	0.01	0.01

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medtronic Stock Analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medtronic Stock Based Compensation from 2010 to 2025

Latest Medtronic PLC's Stock Based Compensation Growth Pattern

Medtronic Stock Based Compensation Regression Statistics

Medtronic Stock Based Compensation History

Other Fundumenentals of Medtronic PLC

Medtronic PLC Stock Based Compensation component correlations

About Medtronic PLC Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Medtronic Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY